The Future of Drug Repositioning. Old Drugs, New Opportunities

Annual Reports in Medicinal Chemistry

Volumn 46, Issue , 2011, Pages 385-401

  Doan, Trinh L ^a   Pollastri, Michael ^b   Walters, Michael A ^a   Georg, Gunda I ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Collaborative networks; Database mining; Drug redirecting; Drug rediscovery; Drug reformulating; Drug repositioning; Drug reprofiling; Drug repurposing; High throughput screening; In silico screening; Indication switching; Indications discovery; Pharmacovigilance; Phenotypic screening; Therapeutic switching

Indexed keywords

EID: 80054121749     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386009-5.00004-7     Document Type: Chapter

References (84)

1. Ashburn T.T., Thor K.B. Nat. Rev. Drug Discov. 2004, 3:673.
2. Tobinick E.L. Drug News Perspect. 2009, 22:119.
3. Carley D.W. IDrugs 2005, 8:306.
4. Buckley C.E., Marguerie A., Roach A.G., Goldsmith P., Fleming A., Alderton W.K., Franklin R.J. Neuropharmacology 2010, 59:149.
5. Ting H.J., Khasawneh F. J. Invest. Med. 2010, 58:208.
6. Bradley D. Nat. Rev. Drug Discov. 2007, 6:423.
7. Cavalla D. Nat. Rev. Drug Discov. 2009, 8:849.
8. Duenas-Gonzalez A., Garcia-Lopez P., Herrera L.A., Medina-Franco J.L., Gonzalez-Fierro A., Candelaria M. Mol. Cancer 2008, 7:82.
9. Dimond P.F. Genet. Eng. Biotech. News 2010, 30.
10. Hopkins A., Lanfear J., Lipinski C., Beeley L. Annu. Rep. Med. Chem. 2005, 40:339.
11. Jarvis L.M. Chem. Eng. News 2010, 88:14.
12. Carley D.W. IDrugs 2005, 8:310.
13. Sleigh S.H., Barton C.L. Pharm. Med. 2010, 24:151.
14. Chong C.R., Sullivan D.J. Nature 2007, 448:645.
15. Goldstein I., Lue T.F., Padma-Nathan H., Rosen R.C., Steers W.D., Wicker P.A. N. Engl. J. Med. 1998, 338:1397.
16. Pfizer Financial Reports http://www.pfizer.com/investors/financial_reports/financial_reports.jsp.
17. Richardson P., Hideshima T., Anderson K. Biomed. Pharmacother. 2002, 56:115.
18. Okafor M.C. Pharmacotherapy 2003, 23:481.
19. FDA Approves Thalomid (thalidomide) to Treat Multiple Myeloma http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm095651.htm.
20. Brogden R.N., Heel R.C. Drugs 1986, 31:96.
21. Cunha B.A. Urology 1993, 41:249.
22. Mulligan M.S., Hevel J.M., Marletta M.A., Ward P.A. Proc. Natl. Acad. Sci. USA 1991, 88:6338.
23. Dietzsch H.J., Gottschalk B., Heyne K., Leupoid W., Wunderlich P. Pediatrics 1975, 55:96.
24. Plosker G.L. Drugs 2010, 70:1843.
25. Waknine Y. Medscape Medical News. http://www.medscape.com/viewarticle/717553.
26. Goldstein D.J., Lu Y., Detke M.J., Hudson J., Iyengar S., Demitrack M.A. Psychosomatics 2004, 45:17.
27. FDA Approves Drug for Neuropathic Pain Associated With Diabetes http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108349.htm.
28. Waknine Y. Medscape Med. News 2008.
29. Skljarevski V., Desaiah D., Liu-Seifert H., Zhang Q., Chappell A.S., Detke M.J., Iyengar S., Atkinson J.H., Backonja M. Spine 2010, 35:E578.
30. Skljarevski V., Zhang S., Chappell A.S., Walker D.J., Murray I., Backonja M. Pain Med. 2010, 11:648.
31. FDA Approves Cymbalta to Treat Chronic Musculoskeletal Pain http://www.drugs.com/newdrugs/fda-clears-cymbalta-chronic-musculoskeletal-pain-2398.html.
32. Eli Lilly Annual Reports http://investor.lilly.com/annuals.cfm.
33. Zon L.I., Peterson R.T. Nat. Rev. Drug Discov. 2005, 4:35.
34. Tsang M. Birth Defects Res. C Embryo Today Rev. 2010, 90:185.
35. Chong C.R., Chen X., Shi L., Liu J.O., Sullivan D.J. Nat. Chem. Biol. 2006, 2:415.
36. Engel J.C., Ang K.K., Chen S., Arkin M.R., McKerrow J.H., Doyle P.S. Antimicrob. Agents Chemother. 2010, 54:3326.
37. Edwards B.S., Oprea T., Prossnitz E.R., Sklar L.A. Curr. Opin. Chem. Biol. 2004, 8:392.
38. Clouser C.L., Patterson S.E., Mansky L.M. J. Virol. 2010, 84:9301.
39. Haeberle S., Zengerle R. Lab Chip 2007, 7:1094.
40. Mark D., Haeberle S., Roth G., von Stetten F., Zengerle R. Chem. Soc. Rev. 2010, 39:1153.
41. Wlodkowic D., Darzynkiewicz Z. World J. Clin. Oncol. 2010, 1:18.
42. Ripphausen P., Nisius B., Peltason L., Bajorath J. J. Med. Chem. 2010, 53:8461.
43. Bisson W.H., Cheltsov A.V., Bruey-Sedano N., Lin B., Chen J., Goldberger N., May L.T., Christopoulos A., Dalton J.T., Sexton P.M., Zhang X.K., Abagyan R. Proc. Natl. Acad. Sci. USA 2007, 104:11927.
44. Butcher E.C., Berg E.L., Kunkel E.J. Nat. Biotechnol. 2004, 22:1253.
45. Lum P.Y., Derry J.M., Schadt E.E. Pharmacogenomics 2009, 10:203.
46. von Eichborn J., Murgueitio M.S., Dunkel M., Koerner S., Bourne P.E., Preissner R. Nucleic Acids Res. 2010, 39:D1060.
47. Fliri A.F., Loging W.T., Volkmann R.A. J. Med. Chem. 2009, 52:8038.
48. Wermuth C.G. Drug Discov. Today 2006, 11:160.
49. CTSA Pharmaceutical Assets Portal http://www.ctsapharmaportal.org.
50. Gower T. Proto. http://protomag.com/assets/drug-repositioning.
51. CTSA Clinical Translational Science Awards: Translating Discoveries to Medical Practice http://www.ctsaweb.org/.
52. Schubert C. Nat. Med. 2010, 16:7.
53. Center for World Health & Medicine at Saint Louis University http://www.cwhm.org/.
54. Collaborative Drug Discovery http://www.collaborativedrug.com/.
55. Milan D.J., Peterson T.A., Ruskin J.N., Peterson R.T., MacRae C.A. Circulation 2003, 107:1355.
56. Compston A., Coles A. Lancet 2008, 372:1502.
57. Ouellet M., Falgueyret J.P., Percival M.D. Biochem. J. 2004, 377:675.
58. NIH researchers create comprehensive collection of approved drugs to identify new therapies for rare and neglected diseases http://www.genome.gov/27544241.
59. The NCGC Pharmaceutical Collection http://tripod.nih.gov/npc/.
60. New robot system to test 10,000 chemicals for toxicity http://www.genome.gov/27543708.
61. The Johns Hopkins Clinical Compound Screening Initiative http://www.jhccsi.org.
62. Miller S.C., Huang R., Sakamuru S., Shukla S.J., Attene-Ramos M.S., Shinn P., Van Leer D., Leister W., Austin C.P., Xia M. Biochem. Pharmacol. 2010, 79:1272.
63. Kumar A., Takada Y., Boriek A.M., Aggarwal B.B. J. Mol. Med. 2004, 82:434.
64. Karin M., Yamamoto Y., Wang Q.M. Nat. Rev. Drug Discov. 2004, 3:17.
65. Schoffski P., Dumez H., Wolter P., Stefan C., Wozniak A., Jimeno J., Van Oosterom A.T. Expert Opin. Pharmacother. 2008, 9:1609.
66. Nare B., Luba J., Hardy L.W., Beverley S. Parasitology 1997, 114(Suppl.):S101.
67. Gourley D.G., Schuttelkopf A.W., Leonard G.A., Luba J., Hardy L.W., Beverley S.M., Hunter W.N. Nat. Struct. Mol. Biol. 2001, 8:521.
68. Ferrari S., Morandi F., Motiejunas D., Nerini E., Henrich S., Luciani R., Venturelli A., Lazzari S., Calo S., Gupta S., Hannaert V., Michels P.A., Wade R.C., Costi M.P. J. Med. Chem. 2011, 54:211.
69. Jimonet P., Audiau F., Barreau M., Blanchard J.C., Boireau A., Bour Y., Coleno M.A., Doble A., Doerflinger G., Huu C.D., Donat M.H., Duchesne J.M., Ganil P., Gueremy C., Honor E., Just B., Kerphirique R., Gontier S., Hubert P., Laduron P.M., Le Blevec J., Meunier M., Miquet J.M., Nemecek C., Mignani S., et al. J. Med. Chem. 1999, 42:2828.
70. Hopkins A.L. Nat. Biotechnol. 2007, 25:1110.
71. Keiser M.J., Setola V., Irwin J.J., Laggner C., Abbas A.I., Hufeisen S.J., Jensen N.H., Kuijer M.B., Matos R.C., Tran T.B., Whaley R., Glennon R.A., Hert J., Thomas K.L., Edwards D.D., Shoichet B.K., Roth B.L. Nature 2009, 462:175.
72. Schuffenhauer A., Zimmermann J., Stoop R., van der Vyver J.-J., Lecchini S., Jacoby E. J. Chem. Inf. Comput. Sci. 2002, 42:947.
73. The Importance of Pharmacovigilance-Safety Monitoring of Medicinal Products http://apps.who.int/medicinedocs/en/d/Js4893e/1.html.
74. Boguski M.S., Mandl K.D., Sukhatme V.P. Science 2009, 324:1394.
75. RADAR (Research on Adverse Drug events And Reports) http://www.cancer.northwestern.edu/research/research_programs/radar/index.cfm.
76. MedWatch: The FDA Safety Information and Adverse Event Reporting Program http://www.fda.gov/Safety/MedWatch/default.htm.
77. Almenoff J., Tonning J.M., Gould A.L., Szarfman A., Hauben M., Ouellet-Hellstrom R., Ball R., Hornbuckle K., Walsh L., Yee C., Sacks S.T., Yuen N., Patadia V., Blum M., Johnston M., Gerrits C., Seifert H., LaCroix K. Drug Saf. 2005, 28:981.
78. Hauben M., Bate A. Pharm. Data Min. 2010, 341.
79. Wang X., Hripcsak G., Markatou M., Friedman C. J. Am. Med. Inf. Assoc. 2009, 16:328.
80. Rizo C., Deshpande A., Ing A., Seeman N. J. Affect. Disord. 2011, 130:290.
81. New iPhone app tracks drug safety http://www.boston.com/news/health/blog/2010/09/new_iphone_app.html.
82. Find the best treatments, feel better faster http://www.curetogether.com/.
83. Seeman N., Ing A., Rizo C. Healthc. Q. 2010, 13(Spec. No.):8.
84. Sproxil, Inc. http://sproxil.com/.